好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effect of a Potential Neurotrophic Drug on the Progression of Dopaminergic Nigro-Striatal Lesions Assessed by 18F-Dopa PET Imaging in Parkinson's Disease
Movement Disorders
(-)
025
Authors/Disclosures
No disclosure on file
Jessica Chorostecki (Wayne State University) No disclosure on file
A J. Stoessl, MD, FAAN (UBC) No disclosure on file
Abraham N. Lieberman, MD, FAAN No disclosure on file
David J. Brooks, MD, DSc, FRCP (Imperial College London) No disclosure on file
Klaus L. Leenders, MD (UMCG) No disclosure on file
Reijo J. Marttila, MD No disclosure on file
Stephane Thobois, MD (Pierre Wertheimer Neurological Hospital) No disclosure on file
No disclosure on file
Francois Vingerhoets, MD (UNIL) No disclosure on file
Philippe Truffinet, MD (Sanofi) Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
Philippe Remy (Neuroscience Dept CHU Henri Mondor) No disclosure on file